Docket Number:11T-1021022
Inventor:Inn-Ho Tsai et al.
IP Status:know-how
Abstract:
- 3 separate cDNAs for RVV-X, Factor-X activating metalloproteinase from Daboia russelii
- 1 cDNA for RVV-V, Factor-V activating serine protease from Daboia russelii
- RVV-X is a heterotrimeric glycoprotein composed of one heavy chain (HC) and two distinct light chains (LC1 and LC2).
- RVV-X is used in diagnostic procedures to quantitatively convert the zymogen factor X into factor Xa which can be determined by means of the clotting assay.
Fields of Application:
RVV-V and RVV-X has served as a tool for thrombosis research and as a diagnostic kit reagent for the detection of coagulation disorders.
Advantages when compared to the existing technologies:
The cDNA can be successfully expressed in mammalian cell and the expressed protein has high coagulation activity. When using this purified protein as a diagnostic reagent or therapeutic treatment, one could avoid the nonspecific interferes or effects by other venom components.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
